This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Molecular Biology Remove Pharma Companies Remove Pharmaceuticals Remove Pharmacy
article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

APRIL 29, 2024

With a background in Bioinformatics and Computational Biology, she has a keen interest in using technology to solve problems in healthcare and medicine. I pursued a degree in Pharmacy from the University of Murcia to become a qualified Pharmacist, followed by an MSc in Cancer Pharmacology at London Metropolitan University.

Bioinformatics 59
Bioinformatics Molecular Biology Drugs Cell Based Assays 59
article thumbnail

Scaling Phage Therapy

Codon

FEBRUARY 13, 2024

3 Another considerable obstacle to pharmaceutical companies’ interest (and investment) is the fact that for a product to be patentable — and therefore profitable — it has to be considered new and inventive. Phage therapies are sold at a pharmacy in Georgia. 4 But the same barriers still exist today. (Its

Therapies 138
Therapies DNA Virus Clinical Trials 138
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 42,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024